HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Association between hemorrhagic transformation after endovascular therapy and poststroke seizures.

AbstractOBJECTIVE:
Endovascular therapy has recently become standard therapy for select patients with acute ischemic stroke. Infarcted brain tissue may undergo hemorrhagic transformation (HT) after endovascular therapy. We investigated the association between HT and occurrence of poststroke seizures in patients treated with endovascular therapy.
METHODS:
Consecutive patients treated with endovascular therapy for acute anterior circulation ischemic stroke were included. HT was assessed with computed tomography/magnetic resonance imaging (CT/MRI) at 24 h after stroke onset. Patients were followed for up to 2 years for seizure occurrence.
RESULTS:
A total of 205 (57.1% male) patients were analyzed. Median age was 69 years (interquartile range [IQR] 57-78). Among patients with HT, 17.9% (10/56) developed poststroke seizures compared with 4.0% (6/149) among those without HT (hazard ratio [HR] 5.52; 95% confidence interval [CI] 2.00-15.22; P = .001). The association remained significant after adjustment for cortical involvement, baseline National Institutes of Health Stroke Scale score, age and use of intravenous tissue plasminogen activator and clot retrieval (HR 4.85; 95% CI 1.60-14.76; P = .005). In patients who developed seizures within the follow-up period, median time to first seizure was 111 days (IQR 28-369) in patients with HT and 36 days (IQR 0.5-183) in patients without HT.
SIGNIFICANCE:
A patient who develops HT following endovascular therapy for acute ischemic stroke had a nearly 5 times higher rate of developing poststroke seizures within 2 years. HT may be used as an imaging biomarker for poststroke seizures.
AuthorsArthur Thevathasan, Jillian Naylor, Leonid Churilov, Peter J Mitchell, Richard J Dowling, Bernard Yan, Patrick Kwan
JournalEpilepsia (Epilepsia) Vol. 59 Issue 2 Pg. 403-409 (02 2018) ISSN: 1528-1167 [Electronic] United States
PMID29288487 (Publication Type: Journal Article)
CopyrightWiley Periodicals, Inc. © 2017 International League Against Epilepsy.
Chemical References
  • Fibrinolytic Agents
  • Tissue Plasminogen Activator
Topics
  • Adult
  • Aged
  • Brain Infarction (diagnostic imaging, drug therapy, surgery)
  • Endovascular Procedures
  • Female
  • Fibrinolytic Agents (therapeutic use)
  • Humans
  • Intracranial Hemorrhages (diagnostic imaging, epidemiology)
  • Magnetic Resonance Imaging
  • Male
  • Middle Aged
  • Postoperative Complications (diagnostic imaging, epidemiology)
  • Postoperative Hemorrhage (diagnostic imaging, epidemiology)
  • Proportional Hazards Models
  • Risk Factors
  • Seizures (epidemiology)
  • Stroke (diagnostic imaging, drug therapy, surgery)
  • Tissue Plasminogen Activator (therapeutic use)
  • Tomography, X-Ray Computed
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: